Paul J. Mellett
2012
In 2012, Paul J. Mellett earned a total compensation of $460.5K as Senior Vice President, Finance Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $117,261 |
|---|---|
| Option Awards | $54,651 |
| Salary | $284,168 |
| Other | $4,439 |
| Total | $460,519 |
Mellett received $284.2K in salary, accounting for 62% of the total pay in 2012.
Mellett also received $117.3K in bonus, $54.7K in option awards and $4.4K in other compensation.
Rankings
In 2012, Paul J. Mellett's compensation ranked 9,002nd out of 11,487 executives tracked by ExecPay. In other words, Mellett earned more than 21.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,002 out of 11,487 | 22nd |
Division Manufacturing | 3,293 out of 4,252 | 23rd |
Major group Chemicals And Allied Products | 891 out of 1,200 | 26th |
Industry group Drugs | 658 out of 922 | 29th |
Industry Pharmaceutical Preparations | 506 out of 697 | 27th |
Source: SEC filing on January 15, 2015.
Mellett's colleagues
We found two more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2012.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019